Adenovirus Rapid Quantitation Kit

Adenovirus Rapid Quantitation Kit
  • Ultra-fast 45-60 minute procedure
  • Measures the viral nucleic acid content of purified adenovirus or unpurified supernatant
  • Limit of detection: 10^10 viral particles/mL from 100 µL of adenoviral supernatant
Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

QuickTiter™ Adenovirus Quantitation Kit
Catalog Number
VPK-106
Size
20 assays
Detection
Fluorometric
Manual/Data Sheet Download
SDS Download
Price
$640.00
Product Details

Quantifying your adenovirus prep prior to infection will help you determine the amount of virus needed to achieve the appropriate MOI (multiplicity of infection) for your target cells. Our QuickTiter™ Adenovirus Quantitation Kit provides a quick method for measuring the viral nucleic acid content of your adenovirus. This assay may be performed either before or after purification of your virus.

Assay Principle for the QuickTiter™ Adenovirus Quantitation Kit.

Recent Product Citations
  1. Stone, A.V. et al. (2020). Role of the Hypoxia-Inducible Factor Pathway in Normal and Osteoarthritic Meniscus and in Mice after Destabilization of the Medial Meniscus. Cartilage. doi: 10.1177/1947603520958143. 
  2. Hossain, E. et al. (2020). Advantages of Using Paclitaxel in Combination with Oncolytic Adenovirus Utilizing RNA Destabilization Mechanism. Cancers (Basel). 12(5). pii: E1210. doi: 10.3390/cancers12051210.
  3. Habiba, U. et al. (2020). Cisplatin Relocalizes RNA Binding Protein HuR and Enhances the Oncolytic Activity of E4orf6 Deleted Adenovirus. Cancers. 12:809. doi: 10.3390/cancers12040809.
  4. Oser, M.G. et al. (2019). The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis. Genes Dev. doi: 10.1101/gad.328336.119.
  5. Yanagawa-Matsuda, A. et al. (2019). Oncolytic potential of an E4-deficient adenovirus that can recognize the stabilization of AU-rich element containing mRNA in cancer cells. Oncol Rep. 41(2):954-960. doi: 10.3892/or.2018.6865.
  6. Yan, Y. et al. (2016). HIV-1 Vpr increases HCV replication through VprBP in cell culture. Virus Res. doi:10.1016/j.virusres.2016.07.007.
  7. Xie, Y. et al. (2016). A recombinant adenovirus expressing P12A and 3C protein of the type O foot-and-mouth disease virus stimulates systemic and mucosal immune responses in mice. BioMed Res Int. doi:10.1155/2016/7849203.
  8. Ran, L. et al. (2016). Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials. 89:56-66.
  9. Nuche-Berenguer, B. et al. (2016). The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling Cascades and in the onset of early pancreatitis events. Biochim Biophys Acta. doi:10.1016/j.bbadis.2016.02.008.
  10. Nuche-Berenguer, B. et al. (2015). Elucidation of the roles of the Src kinases in pancreatic acinar cell signaling. J Cell Biochem. 116:22-36.
  11. Sanchez-Lugo, Y. E. et al. (2014). CXCL10/XCL1 fusokine elicits in vitro and in vivo chemotaxis. Biotechnol Lett. doi:10.1007/s10529-014-1746-4. 
  12. Smith, M. et al. (2010). PRDM1/Blimp-1 Controls Effector Cytokine Production in Human NK Cells. J. Immunol. 185:6058-6067.
  13. Reiter, C.E.N. et al. (2010). Green tea polyphenol epigallocatechin gallate reduceds endothelin 1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1. Endocrinology 151:103-114.
  14. Kang, S-H. et al. (2008). Roles of ERK and NFkB in interleukin-8 expression in response to heat shock protein 22 in vascular smooth muscle cells. Korean J. Physiol. Pharmacol. 12:171-176.
  15. Rho, M. et al. (2007). Sensitization of vascular smooth muscle cell to TNF-alpha-mediated death in the presence of palmitate. Toxicology and Applied Pharmacology 220(3):311-319.
  16. Bian, D. et al. (2006). The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration. Oncogene 25:2234-2244.